CD40-CD40L interactions provide 'third-party' costimulation for T cell response against B7-1-transfected human breast tumor cells

Journal of Leukocyte Biology

Volumn 61, Issue 2, 1997, Pages 201-208

  Pericle, Federica ^a   Epling Burnette, P K ^b   Podack, Eckhard R ^c   Wei, Sheng ^b   Djeu, Julie Y ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c Dept of Microbiology and Immunology ^*  (United States)

Author keywords

CD80; Cytotoxic T lymphocytes; gp39; Transfection

Indexed keywords

CD40 ANTIGEN;

ARTICLE; B LYMPHOCYTE; BREAST CARCINOMA; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031044729     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.61.2.201     Document Type: Article

References (43)

1. Schwartz, R. H. (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71, 1065-1068.
2. Bluestone, J. A. (1995) New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2, 555-559.
3. Robey, E., Allison, J. P. (1995) T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol. Today 16, 306-310.
4. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C., Nadler, L. M. (1991) B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88, 6575-6579.
5. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., Ledbetter, J. A. (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173, 721-730.
6. + T cells. J. Exp. Med. 173, 759-762.
7. June, C. H., Bluestone, J. A., Nadler, L. M., Thompson, C. B. (1994) The B7 and CD28 receptor families. Immunol. Today 15, 321-331.
8. Thompson, C. B., Lindsten, T., Ledbetter, J. A., Kunkel, S. L., Young, H. A., Emerson, S. G., Leiden, J. M., June, C. H. (1989) CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86, 1333-1337.
9. Chen, C., Nabavi, N. (1994) In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1, 147-154.
10. Linsley, P. S., Ledbetter, J. A. (1993) The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
11. Chen, L., Linsley, P. S., Hellstrom, K. E. (1993) Costimulation of T cells for tumor immunity. Immunol. Today 14, 483-486.
12. + T cells by B7-transfected melanoma cells [see comments]. Science 259, 368-370.
13. Chen, L., McGowan, P., Ashe, S., Johnston, J. V., Hellstrom, I., Hellstrom, K. E. (1994) B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. Cancer Res. 54, 5420-5423.
14. Hodge, J. W., Abrams, S., Schlom, J., Kantor, J. A. (1994) Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res. 54, 5552-5555.
15. + T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J. Immunol. 153, 421-428.
16. Wu, T. C., Huang, A. Y., Jaffee, E. M., Levitsky, H. I., Pardoll, D. M. (1995) A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med. 182, 1415-1421.
17. Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellstrom, I., Hellstrom, K. E. (1994) Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179, 523-532.
18. Fanslow, W. C., Clifford, K. N., Seaman, M., Alderson, M. R., Spriggs, M. K., Armitage, R. J., Ramsdell, F. (1994) Recombinant CD40 ligand exerts potent biologic effects on T cells. J. Immunol. 152, 4262-4269.
19. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., van Kooten, C., Liu, Y. J., Rousset, F., Saeland, S. (1994) The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
20. Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., Noelle, R. J. (1994) The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15, 406-411.
21. Jabara, H. H., Fu, S. M., Geha, R. S., Vercelli, D. (1990) CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172, 1861-1864.
22. Kwekkeboom, J., de Rijk, D., Kasran, A., Barcy, S., de Groot, C., de Boer, M. (1994) Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction. Eur. J. Immunol. 24, 508-517.
23. Ramsdell, F., Seaman, M. S., Clifford, K. N., Fanslow, W. C. (1994) CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells. J. Immunol. 152, 2190-2197.
24. + T lymphocytes. J. Immunol. 152, 1523-1531.
25. de Boer, M., Kasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P., Ceuppens, J. L. (1993) Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23, 3120-3125.
26. Yokochi, T., Holly, R. D., Clark, E. A. (1982) B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J. Immunol. 128, 823-827.
27. Clark, E. A., Ledbetter, J. A. (1986) Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83, 4494-4498.
28. Ohe, Y., Zhao, D., Saijo, N., Podack, E. R. (1995) Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer. Hum. Gene Ther. 6, 325-333.
29. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., Linsley, P. S. (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093-1102.
30. Matulonis, U., Dosiou, C., Freeman, G., Lamont, C., Mauch, P., Nadler, L. M., Griffin, J. D. (1996) B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. J. Immunol. 156, 1126-1131.
31. Baskar, S., Ostrand-Rosenberg, S., Nabavi, N., Nadler, L. M., Freeman, G. J., Glimcher, L. H. (1993) Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 90, 5687-5690.
32. Cavallo, F., Martin-Fontecha, A., Bellone, M., Heltai, S., Gatti, E., Tornaghi, P., Freschi, M., Forni, G., Dellabona, P., Casorati, G. (1995) Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol. 25, 1154-1162.
33. + T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155, 45-57.
34. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177, 1791-1796.
35. Dohring, C., Angman, L., Spagnoli, G., Lanzavecchia, A. (1994) T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int. J. Cancer 57, 754-759.
36. Lanier, L. L., O'Fallon, S., Somoza, C., Phillips, J. H., Linsley, P. S., Okumura, K., Ito, D., Azuma, M. (1995) CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154, 97-105.
37. + T lymphocytes. J. Immunol. 148, 1985-1992.
38. Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., Aruffo, A. (1992) A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89, 6550-6554.
39. Springer, T. A. (1990) Adhesion receptors of the immune system. Nature 346, 425-434.
40. Van de Velde, H., von Hoegen, I., Luo, W., Parnes, J. R., Thielemans, K. (1991) The B-cell surface protein CD72/Lyb-2 is the ligand for CD5 [see comments]. Nature 351, 662-665.
41. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.
42. Boon, T. (1993) Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy. Int. J. Cancer 54, 177-180.
43. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., Rosenberg, S. A. (1994) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91, 6458-6462.